Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01433003
What this trial is testing

The Plasma Large-Volume Exchange RCT

Who this might be right for
Purpura, Thrombotic ThrombocytopenicHemolytic Uremic Syndrome
London Health Sciences Centre
Not applicableLooking for participantsNCT06978361
What this trial is testing

Comparison of Efficacy of Microneedling With Platelet Rich Plasma Vs Microneedling With Topical Insulin in the Treatment of Acne Scars

Who this might be right for
Post-acne Atrophic Scars
Khyber Teaching Hospital 116
Testing effectiveness (Phase 2)Study completedNCT01481194
What this trial is testing

ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Vejle Hospital 35
Not applicableStudy completedNCT04542941
What this trial is testing

Assessment of Safety and Efficacy of CCP

Who this might be right for
Covid19
Makerere University 136
Early research (Phase 1)Study completedNCT02652546
What this trial is testing

CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

Who this might be right for
HIV, Inflammation
National Institute of Allergy and Infectious Diseases (NIAID) 38
Testing effectiveness (Phase 2)Ended earlyNCT00843310
What this trial is testing

Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma

Who this might be right for
Multiple Myeloma
NYU Langone Health 8
Testing effectiveness (Phase 2)Study completedNCT01352286
What this trial is testing

Redirected Auto T Cells for Advanced Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 25
Not applicableAvailableNCT03763370
What this trial is testing

Managed Access Program for Combination Treatment With Belantamab Mafodotin in Multiple Myeloma

Who this might be right for
Multiple Myeloma
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT05714969
What this trial is testing

TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)

Who this might be right for
Thrombotic Thrombocytopenic Purpura (TTP)
Takeda 29
Post-approval studies (Phase 4)WithdrawnNCT05183139
What this trial is testing

In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Takeda
Not applicableStudy completedNCT04884477
What this trial is testing

COVID-19 Infection in Patients Receiving Anti-CD20 Therapy

Who this might be right for
COVID-19Immunosuppressed HostConvalescent Plasma+1 more
Mayo Clinic 342
Testing effectiveness (Phase 2)WithdrawnNCT03100877
What this trial is testing

Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma

Who this might be right for
Plasma Cell Leukemia in RemissionPlasma Cell Myeloma
City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT01621672
What this trial is testing

UARK 2009-09 Myeloma Cure Project: Prospective Trial of Indefinite Revlimid Maintenance Versus Observation for Currently Event-Free Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 42
Not applicableStudy completedNCT02417922
What this trial is testing

Effect of Autologous Conditioned Plasma Treatment for Conservative Treated Total Achilles Tendon Tears

Who this might be right for
Tendon Rupture
Bispebjerg Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02969837
What this trial is testing

Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Chicago 46
Very early researchLooking for participantsNCT07249073
What this trial is testing

CAR19-BCMA Dual-target CAR-T in the Treatment of Relapsed / Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 9
Not applicableStudy completedNCT04753073
What this trial is testing

Treatment of Cervical Intraepithelial Neoplasia (CIN) Grade III With Non-invasive Physical Plasma

Who this might be right for
Cervical Intraepithelial Neoplasia III
University Hospital Tuebingen 38
Not applicableUnknownNCT06037928
What this trial is testing

Plasma Sodium and Sodium Administration in the ICU

Who this might be right for
HypernatremiaHyponatremiaCritical Illness
University Hospital, Linkoeping 200
Testing effectiveness (Phase 2)Study completedNCT03164122
What this trial is testing

EVALUATION OF AN INNOVATIVE TREATMENT FOR RADIOCARPAL OSTEOARTHRITIS USING INTRA-ARTICULAR INJECTION OF A MIXTURE OF AUTOLOGOUS MICROFAT AND AUTOLOGOUS PLATELET-RICH PLASMA

Who this might be right for
Osteoarthritis
Assistance Publique Hopitaux De Marseille 12
Not applicableStudy completedNCT02918695
What this trial is testing

Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaHematologic Diseases
Universitaire Ziekenhuizen KU Leuven 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation